fingolimod hydrochloride has been researched along with Autoimmune Experimental Myasthenia Gravis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, T; Duan, RS; Ge, MR; Li, H; Li, XL; Lian, Y; Liu, Y; Liu, YD; Yang, B; Yang, CL; Zhang, P | 1 |
| Diallo, R; Hiepe, F; Kohler, S; Meisel, A; Pelz, A; Schaffert, H | 1 |
| Huang, J; Wang, H; Zhang, T; Zhao, Y | 1 |
| Fujita, T; Hayashi, M; Hirayama, K; Hirose, M; Iwatsuki, R; Kohno, T; Matsumoto, A; Tsuji, T; Watabe, K; Yoshikawa, H | 1 |
4 other study(ies) available for fingolimod hydrochloride and Autoimmune Experimental Myasthenia Gravis
| Article | Year |
|---|---|
Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
Topics: Animals; Antibody-Producing Cells; Autoantigens; Dendritic Cells; Disease Models, Animal; Female; Fingolimod Hydrochloride; Humans; Immunity, Humoral; Immunosuppressive Agents; Myasthenia Gravis; Myasthenia Gravis, Autoimmune, Experimental; Peptides; Rats; Rats, Inbred Lew; Receptors, Cholinergic; T-Lymphocytes, Helper-Inducer | 2021 |
S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset.
Topics: Animals; Antibody Formation; Azetidines; Benzyl Compounds; Cytokines; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphopenia; Male; Mice; Mice, Inbred C57BL; Myasthenia Gravis, Autoimmune, Experimental; Plasma Cells; Receptors, Lysosphingolipid; T-Lymphocytes | 2018 |
Treatment of experimental autoimmune myasthenia gravis rats with FTY720 and its effect on Th1/Th2 cells.
Topics: Animals; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Myasthenia Gravis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Th1 Cells; Th2 Cells | 2018 |
A novel immunomodulator, FTY720, prevents development of experimental autoimmune myasthenia gravis in C57BL/6 mice.
Topics: Animals; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Myasthenia Gravis, Autoimmune, Experimental; Propylene Glycols; Specific Pathogen-Free Organisms; Sphingosine; Time Factors | 2005 |